Doxorubicin induces the persistent activation of intracellular transglutaminase 2 that protects from cell death

Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice

(2011) Keunhee Oh et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Degradation of transglutaminase 2 by calcium-mediated ubiquitination responding to high oxidative stress

(2009) Eui Man Jeong et al.   FEBS LETTERS

Increase in transglutaminase 2 expression is associated with NF-kappaB activation in breast cancer tissues

(2009) Kang-Seo Park   Frontiers in Bioscience-Landmark

Silencing of TGase 2 sensitizes breast cancer cells to apoptosis by regulation of survival factors

(2009) Dae-Seok Kim   Frontiers in Bioscience-Landmark

Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-κB activity in hypoxic tumor cells

(2009) G -Y Jang et al.   ONCOGENE

Transglutaminases and Disease: Lessons From Genetically Engineered Mouse Models and Inherited Disorders

(2009) Siiri E. Iismaa et al.   PHYSIOLOGICAL REVIEWS

Modulation of Cellular Response to Anticancer Treatment by Caffeine: Inhibition of Cell Cycle Checkpoints, DNA Repair and More

(2008) Michal Sabisz et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

TGFβ mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation

(2008) Dong-Myung Shin et al.   FASEB JOURNAL

Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer

(2008) Martin F. Lavin   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Cystamine prevents ischemia–reperfusion injury by inhibiting polyamination of RhoA

(2007) Dong-Myung Shin et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS